Ocular Hypertension Completed Phase 2 Trials for Timolol (DB00373)

Also known as: Intraocular pressure raised / Ocular Hypertension (OHT) / Hypertension Ocular / Hypertension, Ocular / Intraocular pressure high / Intraocular hypertension / Ocular Hypertension (OH) / Elevated intraoccular pressure / Intraocular pressure increased / IOP increased / Raised IOP / Ocular tension increased / Tension ocular increased / Pressure intraocular increased / Increased intraocular pressure

DBCOND0074237 (Ocular Hypertension)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01917383A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle GlaucomaTreatment
NCT01707381BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT01062971Clinical Study of A Fixed Combination of Timolol-Brimonidine-DorzolamideTreatment
NCT01915940Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular HypertensionTreatment
NCT02358369Dose-Ranging Study of the Bimatoprost Ocular InsertTreatment
NCT02312544Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular HypertensionTreatment
NCT02250612SYL040012, Treatment for Open Angle GlaucomaTreatment
NCT01302249AR-12286 in Combination With LatanoprostTreatment
NCT01699464A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 MonthsTreatment
NCT00326092A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00287521A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionTreatment